The ventral tegmental area (VTA) is a key site for opioid actions, and emerging evidence suggests that pain states and opioid experience both induce transcriptional, molecular, and circuit adaptations ...

Highlights Disciplined Capital Allocation While Supporting Continued Nociscan® AdoptionBROOMFIELD, Colo., April 22, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON ...

A sequential, multiple assignment, randomized trial (SMART) found that people with chronic low back pain experienced slight ...

Findings of a real-world study confirm guidelines that recommend physical therapy as first-line treatment; it has a slight edge over cognitive-behavioral therapy.

Rising Demand Drives Pain Management Devices Market Expansion The Pain Management Devices Market has emerged as a critical ...

An evidence-based management algorithm does not improve quality of life or pain severity compared with standard care among ...

Patent covers use of AI in workflows of future products to accelerate company's ability to scale and enhance already strong gross marginsExpands intellectual property portfolio to 64 issued and pendin ...

Patent covers use of AI in workflows of future products to accelerate company’s ability to scale and enhance already strong gross marginsExpands ...

Recognition Follows 2025 HLTH Digital Health Award for NociscanAward Winning AI Targets a Large and Costly Chronic Low Back Pain Market ...

Experts developed a validated multidisciplinary algorithm for diagnosing and treating pelvic venous disorders, using a Delphi consensus process.

Video featuring Mr. John Sutcliffe, Lead Clinician at The London Spine Clinic, highlights real-world physician experience with Nociscan in clinical practice; Nearly 100 Nociscans ...

The agreement brings Nociscan to Weill Cornell Medicine and Och Spine at NewYork-Presbyterian/Weill Cornell Medical Center and the multidisciplinary spine team led by triple-board certified physician ...